These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25669961)

  • 1. Antagonist of prostaglandin E2 receptor 4 induces metabolic alterations in liver of mice.
    Li N; Zhang L; An Y; Zhang L; Song Y; Wang Y; Tang H
    J Proteome Res; 2015 Mar; 14(3):1566-73. PubMed ID: 25669961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EP4 antagonist, L-161,982, induces apoptosis, cell cycle arrest, and inhibits prostaglandin E2-induced proliferation in oral squamous carcinoma Tca8113 cells.
    Li X; Yang B; Han G; Li W
    J Oral Pathol Med; 2017 Nov; 46(10):991-997. PubMed ID: 28342204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of prostaglandin E2-EP4 signaling reduces chemokine production in adipose tissue.
    Tang EH; Cai Y; Wong CK; Rocha VZ; Sukhova GK; Shimizu K; Xuan G; Vanhoutte PM; Libby P; Xu A
    J Lipid Res; 2015 Feb; 56(2):358-68. PubMed ID: 25510249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of prostaglandin E receptor 4 triggers secretion of gut hormone peptides GLP-1, GLP-2, and PYY.
    Coskun T; O'Farrell LS; Syed SK; Briere DA; Beavers LS; Dubois SL; Michael MD; Franciskovich JB; Barrett DG; Efanov AM
    Endocrinology; 2013 Jan; 154(1):45-53. PubMed ID: 23142807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor.
    Aoudjit L; Potapov A; Takano T
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1534-42. PubMed ID: 16396944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
    Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
    J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Characterization of 1
    Yang JJ; Yu WW; Hu LL; Liu WJ; Lin XH; Wang W; Zhang Q; Wang PL; Tang SW; Wang X; Liu M; Lu W; Zhang HK
    J Med Chem; 2020 Jan; 63(2):569-590. PubMed ID: 31855426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and characterization of a potent and selective EP4 receptor antagonist.
    Schiffler MA; Chandrasekhar S; Fisher MJ; Harvey A; Kuklish SL; Wang XS; Warshawsky AM; York JS; Yu XP
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3176-8. PubMed ID: 26091726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist.
    Toyoda H; Terai H; Sasaoka R; Oda K; Takaoka K
    Bone; 2005 Oct; 37(4):555-62. PubMed ID: 16027058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An EP4 antagonist ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer.
    Xu S; Zhang Z; Ogawa O; Yoshikawa T; Sakamoto H; Shibasaki N; Goto T; Wang L; Terada N
    Cell Biochem Biophys; 2014 Sep; 70(1):521-7. PubMed ID: 24744183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.
    Kuriyama S; Kashiwagi H; Yuhki K; Kojima F; Yamada T; Fujino T; Hara A; Takayama K; Maruyama T; Yoshida A; Narumiya S; Ushikubi F
    Thromb Haemost; 2010 Oct; 104(4):796-803. PubMed ID: 20664890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification of substituted benzothiophene derivatives as PGE(2) subtype 4 receptor antagonists: From acid to non-acid.
    Li L; Mathieu MC; Denis D; Therien AG; Wang Z
    Bioorg Med Chem Lett; 2011 Jan; 21(2):734-7. PubMed ID: 21208803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells.
    Friis UG; Stubbe J; Uhrenholt TR; Svenningsen P; Nüsing RM; Skøtt O; Jensen BL
    Am J Physiol Renal Physiol; 2005 Nov; 289(5):F989-97. PubMed ID: 15985651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of AAT-008, a novel, potent, and selective prostaglandin EP4 receptor antagonist.
    Okumura Y; Yamagishi T; Nukui S; Nakao K
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1186-1192. PubMed ID: 28169162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of PGE2 EP3/EP4 receptors on bladder dysfunction in mice with experimental autoimmune encephalomyelitis.
    Xue R; Jia Z; Kong X; Pi G; Ma S; Yang J
    Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1656-62. PubMed ID: 24154697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prostaglandin E receptor subtypes EP2 and EP4 in autocrine and paracrine functions of vascular endothelial growth factor in the inner ear.
    Hori R; Nakagawa T; Yamamoto N; Hamaguchi K; Ito J
    BMC Neurosci; 2010 Mar; 11():35. PubMed ID: 20219142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral prostaglandin E2 prolongs the sensitization of nociceptive dorsal root ganglion neurons possibly by facilitating the synthesis and anterograde axonal trafficking of EP4 receptors.
    St-Jacques B; Ma W
    Exp Neurol; 2014 Nov; 261():354-66. PubMed ID: 24910202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of substituted-2,4-dimethyl-(naphthalene-4-carbonyl)amino-benzoic acid as potent and selective EP4 antagonists.
    Blanco MJ; Vetman T; Chandrasekhar S; Fisher MJ; Harvey A; Mudra D; Wang XS; Yu XP; Schiffler MA; Warshawsky AM
    Bioorg Med Chem Lett; 2016 Jan; 26(1):105-9. PubMed ID: 26608552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin EP4 receptor enhances BCR-induced apoptosis of immature B cells.
    Prijatelj M; Celhar T; Mlinaric-Rascan I
    Prostaglandins Other Lipid Mediat; 2011 Aug; 95(1-4):19-26. PubMed ID: 21600299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.